Antithrombotic therapy in valvular heart disease (Q28180842)

Clinics in geriatric medicine

Europe PubMed Central

title

Antithrombotic therapy in valvular heart disease (English)

0 references

author name string

P D Stein

series ordinal

1

0 references

language of work or name

English

0 references

publication date

February 2001

0 references

published in

0 references

volume

17

0 references

issue

1

0 references

page(s)

163-72, viii

0 references

cites work

AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Long-term results with the Medtronic-Hall valvular prosthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Comparison of high-dose with low-dose aspirin in patients with mechanical heart valve replacement treated with oral anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Long-term results of the Carpentier-Edwards pericardial aortic valve: a 12-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Mitral annular calcification and the risk of stroke in an elderly cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Management of Thrombo-Embolism after Aortic Valve Replacement with the Björk-Shiley Tilting Disc Valve: Medicamental Prevention with Dicumarol in Comparison with Dipyridamole—Acetylsalicylic Acid. Surgical Treatment of Prosthetic Thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Pericarbon pericardial valve prosthesis: midterm results of the aortic valve replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Optimal oral anticoagulant therapy in patients with mechanical heart valves.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

PATIENTS WITH MITRAL STENOSIS AND SYSTEMIC EMBOLI; HEMODYNAMIC AND CLINICAL OBSERVATIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Twenty-year follow-up of the Hancock modified orifice porcine aortic valve

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Systemic embolism in mitral valve disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

The Hancock II bioprosthesis at 12 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Mitral valve replacement: randomized trial of St. Jude and Medtronic Hall prostheses

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Determinants of 15-year outcome with 1,119 standard Carpentier-Edwards porcine valves

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Aging and the anticoagulant response to warfarin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Risk factors for intracranial hemorrhage in outpatients taking warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Carpentier-Edwards standard porcine bioprosthesis: a 21-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Medtronic intact porcine bioprosthesis: 10 years' experience

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Carpentier-Edwards supraannular porcine bioprosthesis evaluation over 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

A 20-year experience with the Hancock porcine xenograft in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Aortic valve replacement with the St. Jude Medical prosthesis and fixed dose anticoagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Long-term follow-up of St. Jude Medical prosthesis in a young rheumatic population using low-level warfarin anticoagulation: an analysis of the temporal distribution of causes of death

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Nonbacterial thrombotic endocarditis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Thromboembolic and other events following valve replacement in a pediatric population treated with antiplatelet agents

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Silent infarcts in patients with ischemic stroke are related to age and size of the left atrium.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Aging and warfarin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: a 12-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

15-year experience with the Carpentier-Edwards pericardial bioprosthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Effects of dipyridamole in combination with anticoagulant therapy on survival and thromboembolic events in patients with prosthetic heart valves. A meta-analysis of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Antithrombotic Therapy in Valvular Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Use of enoxaparin for the chronically anticoagulated patient before and after procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Continuing disease process of calcific aortic stenosis. Role of microthrombi and turbulent flow

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Eight years' experience with the Medtronic-Hall valve prosthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Considerations in selection and management of patients undergoing valve replacement with glutaraldehyde-fixed porcine bioprotheses

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021

Low-dose anticoagulant management of patients with St. Jude Medical mechanical valve prostheses

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970112-9

7 January 2021